James B Hermiller Jr. MD

Cardiology•Indianapolis, IN

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to View Full Profile

10590 N Meridian StIndianapolis, IN 46290
Phone+1 317-338-6666
Fax+1 317-338-6066

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1989 - 1992
National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
Ohio State University College of MedicineClass of 1983

Certifications & Licensure

IN State Medical License 1992 - 2027
NC State Medical License 1991 - 1998
MD State Medical License 1988 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1) Start of enrollment: 2008 Jul 01
Completed
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Start of enrollment: 2009 Aug 01
Completed
Phase 4
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) Start of enrollment: 2008 Jul 01
Completed
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
Completed
Not Applicable
RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT) Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Start of enrollment: 2012 Nov 13
Terminated
Phase 1, Phase 2
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
ACTIVE_NOT_RECRUITING
NA
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
ACTIVE_NOT_RECRUITING
Edwards EVOQUE Eos MISCEND Study Start of enrollment: 2015 Feb 06
ACTIVE_NOT_RECRUITING
NA
WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Start of enrollment: 2017 Dec 15
Completed
Not Applicable
Portico Next Generation Approval Study Start of enrollment: 2019 Sep 17
ACTIVE_NOT_RECRUITING
NA
MitraClip REPAIR MR Study Start of enrollment: 2020 Jul 21
RECRUITING
NA
Join now to see all

Publications & Presentations

PubMed

Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study.
Raul Moreno, Sergio Bravo Baptista, Borja Rivero-Santana, Jose Valencia, Antonio Gomez-Menchero
International Journal of Cardiology. 2026-01-01
1 citations
CLASP IID Trial and Registry: 2-Year Outcomes of Transcatheter Repair for Degenerative Mitral Regurgitation.
Raj Makkar, Firas Zahr, Tarun Chakravarty, Scott Chadderdon, Moody Makar
JACC. Cardiovascular Interventions. 2025-10-13
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Philipp Lurz, Rebecca T Hahn, Susheel Kodali, Raj Makkar, Rahul P Sharma
European Heart Journal. 2025-08-29

Lectures

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
An Optimized, Upfront Two-Stent Strategy (a.k.a. DK Crush) Is My New Standard!
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
TCT 77: Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: Real World Comparative Outcomes Utilizing the TVT Registry
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Delivering Evidence
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
The Growing Concern of Coronary Access After TAVR: Procedural Problem-Solving and Impact on TAVR Device Choices
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Interventional Live Case Session IV: Coronary Transmission from University of Washington Medical Center
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
2012 Scientific Sessions of the Society for Cardiovascular Angiography & Interventions (SCAI)
Society for Cardiovascular Angiography and Interventions, Las Vegas, Nevada - 5/9/2012
Join now to see all

Press Mentions

High-Definition IVUS vs OCT: Lumen Size and Plaque MorphologyOctober 20th, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in WomenSeptember 18th, 2025
Srihari S. Naidu, MD, MSCAI, Discusses SCAI and His Presidency YearSeptember 3rd, 2025
Join now to see all